The independent financial analyst theScreener just lowered the general evaluation of GENOMIC HEALTH INCO. (US), active in the Biotechnology industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date October 25, 2019, the clo...
Key Points: • Homebuilders remain a leadership Group in the Consumer Discretionary Sector (ex. MDC, LGIH, CCS, and BLD) • Insurance related names continue to be leadership. (ex. AJG, BRO, AON, and WLTW) • Technology continues to have a number of attractive technical charts. (ex. AMAT, LRCX, SGH, CEVA, MU, EVTC, CSGS, SAIC, COHR, WDC, and STX)
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.